BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 29455447)

  • 21. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
    Naghavi AO; Echevarria MI; Grass GD; Strom TJ; Abuodeh YA; Ahmed KA; Kim Y; Trotti AM; Harrison LB; Yamoah K; Caudell JJ
    Cancer; 2016 Nov; 122(22):3529-3537. PubMed ID: 27479362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer.
    Zhang Y; Franzini L; Chan W; Xu H; Du XL
    J Health Care Poor Underserved; 2015 Nov; 26(4):1336-58. PubMed ID: 26548682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of radiotherapy costs on clinical outcomes in breast cancer.
    Boero IJ; Paravati AJ; Triplett DP; Hwang L; Matsuno RK; Mell LK; Murphy JD
    Radiother Oncol; 2015 Nov; 117(2):393-9. PubMed ID: 26472317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-state relative survival modelling of colorectal cancer progression and mortality.
    Gilard-Pioc S; Abrahamowicz M; Mahboubi A; Bouvier AM; Dejardin O; Huszti E; Binquet C; Quantin C
    Cancer Epidemiol; 2015 Jun; 39(3):447-55. PubMed ID: 25819431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system.
    Zullig LL; Williams CD; Fortune-Britt AG
    Cancer Manag Res; 2015; 7():19-35. PubMed ID: 25609998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
    Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
    JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between quality, spending and outcomes among women with breast cancer.
    Hassett MJ; Neville BA; Weeks JC
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast reconstruction after mastectomy among Department of Defense beneficiaries by race.
    Enewold LR; McGlynn KA; Zahm SH; Poudrier J; Anderson WF; Shriver CD; Zhu K
    Cancer; 2014 Oct; 120(19):3033-9. PubMed ID: 24965236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance mammography among female Department of Defense beneficiaries: a study by race and ethnicity.
    Enewold L; McGlynn KA; Zahm SH; Jatoi I; Anderson WF; Gill AA; Shriver CD; Zhu K
    Cancer; 2013 Oct; 119(19):3531-8. PubMed ID: 23913448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
    Landrum MB; Keating NL; Lamont EB; Bozeman SR; Krasnow SH; Shulman L; Brown JR; Earle CC; Rabin M; McNeil BJ
    J Clin Oncol; 2012 Apr; 30(10):1072-9. PubMed ID: 22393093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethnic differences in breast cancer survival: status and determinants.
    Maskarinec G; Sen C; Koga K; Conroy SM
    Womens Health (Lond); 2011 Nov; 7(6):677-87. PubMed ID: 22040209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries.
    Enewold L; Zhou J; McGlynn KA; Devesa SS; Shriver CD; Potter JF; Zahm SH; Zhu K
    Cancer; 2012 Mar; 118(5):1397-403. PubMed ID: 21837685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial variation in breast cancer treatment among Department of Defense beneficiaries.
    Enewold L; Zhou J; McGlynn KA; Anderson WF; Shriver CD; Potter JF; Zahm SH; Zhu K
    Cancer; 2012 Feb; 118(3):812-20. PubMed ID: 21766298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.
    Stokes ME; Thompson D; Montoya EL; Weinstein MC; Winer EP; Earle CC
    Value Health; 2008; 11(2):213-20. PubMed ID: 18380633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of longitudinal multinomial outcome data.
    Li YP; Chan W
    Biom J; 2006 Apr; 48(2):319-26. PubMed ID: 16708781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities and survival among breast cancer patients.
    Field TS; Buist DS; Doubeni C; Enger S; Fouayzi H; Hart G; Korner EJ; Lamerato L; Bachman DJ; Ellis J; Herrinton L; Hornbrook MC; Krajenta R; Liu L; Yao J
    J Natl Cancer Inst Monogr; 2005; (35):88-95. PubMed ID: 16287892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system.
    Jatoi I; Becher H; Leake CR
    Cancer; 2003 Sep; 98(5):894-9. PubMed ID: 12942554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship of HMOs, health insurance, and delivery systems to breast cancer outcomes.
    Lee-Feldstein A; Feldstein PJ; Buchmueller T; Katterhagen G
    Med Care; 2000 Jul; 38(7):705-18. PubMed ID: 10901354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of sojourn time in chronic disease screening without data on interval cases.
    Chen TH; Kuo HS; Yen MF; Lai MS; Tabar L; Duffy SW
    Biometrics; 2000 Mar; 56(1):167-72. PubMed ID: 10783792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.